BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome

Clinical trial NCT05703542 · RECRUITING

Trial details

NCT number: NCT05703542
Sponsor: Eric Stephen Winer, MD
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndrome With Excess Blasts-2

Start date: 2023-02-02
Primary completion: 2026-03-17
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.